Lantheus Holdings, Inc. LNTH

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $100.94
Market Cap $6.57B
P/E Ratio 29.60
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑0.5% YoY
$1.54B
3-Yr CAGR: 18.1%
Net Income ↓-25.2% YoY
$233.56M
Net Margin: 15.2%
Free Cash Flow ↓-28.2% YoY
$354.05M
FCF Yield: 5.39%
EPS (Diluted) ↓-21.8% YoY
$3.41
Basic: $3.46
Return on Equity Efficiency
21.4%
ROA: 26.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (LNTH)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $301.9M $137.8M $26.8M $0.82 $49.6M $42.2M
FY 2017 $331.4M +9.8% $162.1M $123.4M +361.0% $3.17 +286.6% $54.8M $37.2M -11.9%
FY 2018 $343.4M +3.6% $174.9M $40.5M -67.2% $1.03 -67.5% $61.2M $41.1M +10.3%
FY 2019 $347.3M +1.2% $174.8M $31.7M -21.8% $0.79 -23.3% $80.4M $58.3M +42.0%
FY 2020 $339.4M -2.3% $138.8M $-13.5M -142.5% $-0.25 -131.6% $16.4M $3.9M -93.3%
FY 2021 $425.2M +25.3% $187.7M $-71.3M -429.1% $-1.06 -324.0% $53.9M $41.8M +965.2%
FY 2022 $935.1M +119.9% $581.7M $28.1M +139.4% $0.40 +137.7% $281.8M $263.4M +530.6%
FY 2023 $1,296.4M +38.6% $709.5M $326.7M +1,063.9% $4.65 +1,062.5% $305.3M $258.7M -1.8%
FY 2024 $1,533.9M +18.3% $988.3M $312.4M -4.4% $4.36 -6.2% $544.8M $493.1M +90.6%
FY 2025 $1,541.6M +0.5% $942.0M $233.6M -25.2% $3.41 -21.8% $390.1M $354.1M -28.2%
$

Valuation

Market Price $100.94
Market Cap $6.57B
Enterprise Value $6.21B
P/E Ratio 29.60
P/B Ratio 6.03
FCF Yield 5.39%
Dividend Yield N/A
Shares Outstanding 65,106,100
%

Profitability & Margins

Gross Margin 61.10%
Operating Margin 20.16%
Net Margin 15.15%
Return on Equity (ROE) 21.43%
Return on Assets (ROA) 25.95%
Asset Turnover 1.71x
Revenue 3-Yr CAGR 18.13%
🛡️

Financial Health & Liquidity

Current Ratio 2.70
Cash Ratio 1.08
Debt / Equity 0.001
Debt / Assets 0.002
Cash & Equivalents $359.12M
Total Debt $1.48M
Book Value / Share $16.74
💧

Cash Flow Efficiency

Operating Cash Flow $390.14M
Capital Expenditures (CapEx) $36.09M
Free Cash Flow $354.05M
OCF / Revenue 25.31%
FCF / Revenue 22.97%
FCF 3-Yr CAGR 10.36%
🏷️

Per Share Metrics

EPS (Diluted) $3.41
EPS (Basic) $3.46
Dividends / Share N/A
Book Value / Share $16.74
EPS YoY Growth -21.79%
🏛️

Balance Sheet (FY 2025)

Total Assets $899.96M
Total Liabilities $333.42M
Stockholders' Equity $1.09B
Current Assets $899.96M
Current Liabilities $333.42M